Tag: Cancer Research
-
The Pap Corps Makes Historic $8.4 Million Donation for Cancer Research – Sylvester Comprehensive Cancer Center to Benefit from Nonprofit’s Largest Gift
DEERFIELD BEACH, Fla. — The Pap Corps Champions for Cancer Research (thepapcorps.org) recently presented a historic donation to Sylvester Comprehensive Cancer Center of $8.4 million. This gift came in two parts, $3.4 million through the volunteers’ fundraising efforts and $5 million from an anonymous donor. This is the largest single gift in the nonprofit’s 70-year…
-
The Pap Corps Celebrates 70 Years of Funding Research for All Types of Cancer
DEERFIELD BEACH, Fla. — The Pap Corps Champions for Cancer Research will celebrate its 70th anniversary with a beautiful luncheon event at the Polo Club in Boca Raton on Tuesday, November 15, 2022. During the past seven decades, the nonprofit has grown from a small group of women supporting the pioneering work of Dr. George…
-
The Pap Corps Donates $3.5 Million to Sylvester Comprehensive Cancer Center
DEERFIELD BEACH, Fla. — You can’t keep champions down! Rebounding from COVID-19, The Pap Corps Champions for Cancer Research came back full swing with their fundraising for the 2021/2022 fiscal year. At their May meeting, the 501(c)(3) nonprofit donated $3.5 million to Sylvester Comprehensive Cancer Center.
-
NED Biosystems Announces Leading Infectious Disease Research Scientist Michael Mansour, MD, PhD To Serve as Medical Advisor
CAMBRIDGE, Mass. — NED Biosystems, an innovative clinical-stage biotech company developing therapies for cancer and the novel coronavirus, is pleased to announce that Michael Mansour, MD, PhD, will serve as the Company’s Medical Advisor of Infectious Disease.
-
Leading Experts in Cancer Research Nabeel El-Bardeesy and Razelle Kurzrock Join NED Biosystems’ Scientific Advisory Board
CAMBRIDGE, Mass. — NED Biosystems, an innovative clinical-stage biotech company developing oral therapies for cancer and novel coronavirus, is pleased to announce that Nabeel El-Bardeesy, PhD and Razelle Kurzrock, MD have joined the Company’s Scientific Advisory Board.
-
Mira and the National Foundation for Cancer Research to expand COVID Care and tackle health disparities
NEW YORK, N.Y. — Mira, a healthcare company based in NYC, is partnering with the National Foundation for Cancer Research (NFCR) to provide COVID Care to cancer patients and caregivers, bringing healthcare closer to those who need it the most.
-
iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting
STONY BROOK, N.Y. — iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to…
-
The Pap Corps Receives $100,000 Matching Gift Challenge by The Yass Family
BOCA RATON, Fla. — The Pap Corps Champions for Cancer Research has announced a $100,000 matching gift challenge by The Yass Family. This gift will be utilized to enhance the 2018 Dr. Kevin Berkowitz Memorial End of Year Giving Campaign, which will be directed towards melanoma research at Sylvester Comprehensive Cancer Center at the University…
-
The Pap Corps Hosts Inaugural Yacht Hop and Waterside Soiree to Raise Cancer Research Funds
DEERFIELD BEACH, Fla. — The Pap Corps, Champions for Cancer Research is proud to announce that acclaimed movement artist/choreographer Jon Boogz and The Aqualillies will be headlining their “Inaugural Yacht Hop & Waterside Soiree.” The mega night of mega yachts will take place on Saturday, April 7, 2018 at the famed Turnberry Marina and Turnberry…
-
Nationally Renowned Research Doctor Will Discuss His New Hopes, Methods, and Successes with Treating Rare Children’s Cancers on Nov. 5, 2017
LAKE FOREST, Calif. — Jareds Juggernaut To Cure Sarcoma, a non-profit which funds researchers of body sparing cancer treatments targeted for rare children’s cancers, today announced an event which features Dr. Charles Keller as the keynote speaker, which will take place on November 5, 2017 in the Sun and Sail Club in Lake Forest, Calif.